CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jinling Pharmaceutical Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jinling Pharmaceutical Co., Ltd.
Jinling Medicine Mansion
No.238 Zhongyang Road
Phone: +86 2583118511p:+86 2583118511 NANJING, JNG  210009  China Ticker: 000919000919
Business Summary
Jinling Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture of medicines and medical devices and medical health care services. The manufacture of medicines and medical devices refers to the production of traditional Chinese medicines, chemical medicines and medical devices. The sales of medicines and medical devices refers to the sales of self-produced medicines and agent medicines and medical devices. Medical health care services are mainly provided by hospitals and health care services provided by welfare centers. The Company's main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The Company's products are mainly sold in the domestic Chinese market, with East China as its main market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8062 General medical and surgical hospitals

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ShengChen 54 6/28/2023 6/1/2019
President, Director HaiChen 43 1/8/2024 7/9/2022
Finance Director, Chief Accounting Officer, Vice President, Secretary of the Board, Director YangWang 45 1/8/2024 6/30/2017
12 additional Officers and Directors records available in full report.

Business Names
Business Name
000919
Jinling Pharmaceutical Co., Ltd.

General Information
Number of Employees: 4,871 (As of 12/31/2023)
Outstanding Shares: 623,708,628 (As of 11/14/2024)
Shareholders: 45,672
Stock Exchange: SHE
Fax Number: +86 2583112486


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 27, 2025